<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02293499</url>
  </required_header>
  <id_info>
    <org_study_id>RSRB00053987</org_study_id>
    <nct_id>NCT02293499</nct_id>
  </id_info>
  <brief_title>Peer Led Asthma Self Management for Adolescents: PLASMA</brief_title>
  <acronym>PLASMA</acronym>
  <official_title>Peer Led Asthma Self Management for Adolescents: PLASMA</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Tennessee</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Rochester</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Asthma is a serious chronic health condition particularly in inner-city adolescents, who&#xD;
      suffer disproportionately high asthma-related morbidity and mortality that place heavy&#xD;
      economic burdens on families and society. There is a consensus that adverse asthma outcomes&#xD;
      can be ameliorated by an individual's active engagement in adequate self-management. This&#xD;
      multi-site randomized controlled study proposes to implement and evaluate a peer-led asthma&#xD;
      self-management for adolescents (PLASMA) program that has demonstrated its feasibility and&#xD;
      preliminary efficacy in a previous study. PLASMA will be implemented in three cities (Buffalo&#xD;
      NY, Baltimore MD, and Memphis TN) that have particularly high rates of pediatric asthma and&#xD;
      asthma-related morbidity, and are thus most likely to benefit from the program. PLASMA&#xD;
      comprises three main components: (a) peer-leader training; (b) a one-day asthma camp where&#xD;
      peer leaders will deliver manualized self-management content recommended by the national&#xD;
      guidelines; and (c) bi-monthly peer-leader contacts. Specific aims are: (1) to evaluate the&#xD;
      effectiveness of PLASMA in inner-city adolescents with asthma in improving quality of life&#xD;
      (primary outcome), and asthma knowledge, attitudes, outcome expectations, self-efficacy,&#xD;
      self-management skills, and asthma control, FEV1 (exploratory outcomes) over time, compared&#xD;
      to a control group for whom adult leaders will deliver the same program content; (2) to&#xD;
      examine the mediating effects of the exploratory outcomes on quality of life; (3) to examine&#xD;
      the moderating effects of personal factors (e.g., age, sex, family support) on the&#xD;
      intervention's primary and exploratory outcomes; (4) to evaluate the effects of PLASMA on&#xD;
      study outcomes in peer leaders (16-20 years); and (5) to determine the economic impact of the&#xD;
      intervention. These aims will be accomplished using a two-group randomized controlled trial&#xD;
      with 378 adolescents (12-17 years) from the three cities (126 for each site). A total of 42&#xD;
      qualified peer leaders (14 in each site) will be enrolled based on adult nomination.&#xD;
      Eligibility criteria for both peer leaders and adolescent learners include: a current asthma&#xD;
      diagnosis; persistent asthma; absence of other chronic or mental illness; inner-city&#xD;
      residence; and capability of verbal and written communication in English. Participants will&#xD;
      provide data at enrollment (T1), camp (T2), and at 3-, 6-, 9-, 12-, and 15-months post-camp&#xD;
      (T3-T7). Data will be analyzed using a multi-site hierarchical three-level linear&#xD;
      mixed-effects model where level 1 represents repeated measures, level 2 = subject, and level&#xD;
      3 = site. To determine the economic impact of the program, investigator will measure the&#xD;
      direct healthcare costs and total costs of the program, and perform net cost analyses for&#xD;
      each type of costs. In addition, investigator will estimate cost-effectiveness ratios of the&#xD;
      PLASMA group compared with the control.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Asthma, the most common pediatric chronic condition, is a serious problem for many&#xD;
      adolescents. In 2010, nearly 11% of adolescents (2.7 million) ages 12 through 17 years in the&#xD;
      US reported current asthma. This age cohort suffers greater asthma-related morbidity and&#xD;
      mortality than younger children. Asthma disproportionately affects inner-city youth, where&#xD;
      asthma severity has increased and achieving optimum asthma control has been elusive. Several&#xD;
      factors including poor socioeconomic conditions, life stresses, and environmental triggers&#xD;
      have been found to be associated with poorly controlled asthma in inner-city children.&#xD;
      Programs targeting asthma in inner-city children have primarily focused on the modification&#xD;
      of environmental factors and addressing disparity in healthcare access. Limited intervention&#xD;
      efforts have been directed to address high inner-city asthma morbidity specifically in&#xD;
      adolescents by promoting adequate self-management.&#xD;
&#xD;
      Dr. Rhee successfully completed an R21 (NR009837) where she designed an evidence-based&#xD;
      peer-led asthma self-management for adolescents (PLASMA) program and tested its efficacy in a&#xD;
      randomized parallel group design in 112 urban and suburban adolescents with persistent&#xD;
      asthma. The PLASMA program was implemented at a one-day camp and involved monthly follow-ups&#xD;
      by peer leaders. The program was well received by participants, and relative to adolescents&#xD;
      who received an adult-led program, the PLASMA group reported better quality of life and&#xD;
      asthma control and fewer asthma-related urgent office visits. Subgroup analysis revealed that&#xD;
      the program was particularly effective for inner-city adolescents in improving asthma&#xD;
      outcomes compared with suburban participants. Given the disproportionate burdens of asthma in&#xD;
      inner-city youth and the program's compelling effects in this population, focusing on&#xD;
      inner-city adolescents as a target of the PLASMA program is critical.&#xD;
&#xD;
      Building on this previous trial of efficacy, the overall goal of the proposed study is to&#xD;
      evaluate the effectiveness and generalizability of the peer-led intervention, PLASMA, in&#xD;
      improving asthma outcomes in inner-city adolescents from three metropolitan cities in the&#xD;
      Northern, Eastern and Southern US with distinctive historical and cultural backgrounds.&#xD;
      Multisite studies have been advocated as an effective approach to strengthening external&#xD;
      validity as such studies afford the opportunity to assess the extent to which treatment&#xD;
      effects are generalizable to different settings. Ascertaining generalizability across sites&#xD;
      is important as it guides future translation of study findings into policy and practice. This&#xD;
      study will also determine long-term sustainability of PLASMA effects and estimate the&#xD;
      economic impact of the intervention. This multi-site study is significant in that it will&#xD;
      target the understudied population, inner-city adolescents with asthma in three cities in the&#xD;
      US, who present serious challenges to optimum asthma management.&#xD;
&#xD;
      Specific study aims are:&#xD;
&#xD;
        1. To evaluate systematically the effectiveness of a peer-led asthma program in inner-city&#xD;
           adolescents with persistent asthma. This aim will be accomplished by using a two-group&#xD;
           randomized controlled trial with 378 adolescents (12-17 years) from the three cities.&#xD;
           The intervention group will receive PLASMA involving peer leader training, a one-day&#xD;
           intense asthma self-management program led by peer leaders and bimonthly contacts from&#xD;
           peer leaders. Intervention effects will be examined in comparison to the control group,&#xD;
           who will receive the same program content delivered by adult leaders. Investigators&#xD;
           hypothesize that: relative to the control group, the PLASMA group will report greater&#xD;
           improvement over time in (H1) quality of life (primary outcome), and (H2) asthma&#xD;
           knowledge, attitudes, outcome expectations, self-efficacy, self-management skills, and&#xD;
           asthma control, FEV1 (exploratory outcomes). (H3) The post-PLASMA scores on outcome&#xD;
           measures will be higher than pre-program scores from both treatment groups.&#xD;
&#xD;
        2. To examine the mediating effects of the secondary outcomes (knowledge, attitudes,&#xD;
           outcome expectations, self-efficacy, self-management skills, asthma control, and FEV1)&#xD;
           on the primary outcome (quality of life) of the intervention.&#xD;
&#xD;
        3. To examine the moderating effects of personal factors (e.g., age, sex, family support)&#xD;
           on primary and secondary outcomes of the intervention.&#xD;
&#xD;
        4. To evaluate the effects of PLASMA on primary and exploratory outcomes in peer leaders&#xD;
           (16-20 years). Investigators hypothesize that the peer leaders (n=42) will report&#xD;
           significant improvement in quality of life (primary outcome) and secondary outcomes&#xD;
           (knowledge, attitudes, outcome expectations, self-efficacy, self-management skills,&#xD;
           asthma control and FEV1) over the course of 15 months.&#xD;
&#xD;
        5. To determine the economic impact of the intervention. This aim will be accomplished by&#xD;
           (5a) measuring the direct healthcare costs and total costs of the PLASMA program, as&#xD;
           compared with the control group; (5b) performing net cost analyses for each type of&#xD;
           costs; and (5c) estimating cost-effectiveness ratios of the PLASMA group compared with&#xD;
           the control. Investigators hypothesize that the direct and overall costs per participant&#xD;
           in the PLASMA group will be less than costs per participant in the control group, or&#xD;
           cost neutral.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 14, 2015</start_date>
  <completion_date type="Actual">February 28, 2019</completion_date>
  <primary_completion_date type="Actual">February 28, 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Given the overt nature of the intervention, blinding either participants or investigators was not achieved although we did not inform participants of their group membership explicitly.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>The Pediatric Asthma Quality of Life Questionnaire (PAQOL)</measure>
    <time_frame>15 months</time_frame>
    <description>a 23-item instrument, 118 consists of three subdomains: activity limitation (5 items), emotional function (8 items), and symptoms (10 items). Higher scores indicate better levels of functioning. This scale has proved a valid and reliable measure of asthma-specific quality of life in adolescents. Mean scores are reported, and range from 1 to 7. Higher score indicating higher quality of life.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adolescent Asthma Knowledge Questionnaire (AAK)</measure>
    <time_frame>15 months</time_frame>
    <description>This 30-item instrument is a modification of the original 27-item questionnaire measuring children's knowledge of triggers and symptom identification and asthma management procedures. Total score range from 0 to 30, with higher score indicating greater knowledge.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Attitude Toward Asthma Scale (ATA)</measure>
    <time_frame>15 months</time_frame>
    <description>This 13-item scale measures children's attitudes toward their asthma on a 5-point Likert-type scale. Mean score ranges from 1 to 5, with higher score indicating a more positive attitude.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Asthma Self-Efficacy (ASE)</measure>
    <time_frame>15 months</time_frame>
    <description>This 14-item instrument measured on a 5-point scale (from 1='not at all sure' to 5='completely sure') assesses a child's confidence in attack prevention (e.g., learning asthma self-management skills, correct use of medication) and attack management (e.g., control symptoms, decide which medication to use). A total score was computed, ranging from 14 and 70, with higher values indicating greater self-efficacy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Asthma Outcome Expectation Scale (AOE)</measure>
    <time_frame>15 months</time_frame>
    <description>This 5 items scale measured on a 9-point scale from 'not all all (1)' to 'extremely (9)' assess the construct of &quot;outcome expectations&quot; derived from social cognitive theory. The average score was computed, ranging from 1 to 9, with higher scores suggesting more positive expectations about performing actions of asthma self-management.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Asthma Prevention Index</measure>
    <time_frame>15 months</time_frame>
    <description>This is one of 3 subscales of asthma self-management indices developed for adolescents with asthma. The prevention index consists of 11 items measured on a 3-point scale. An average score based on items 1-9 was computed, ranging from 1 to 3, with higher scores suggesting greater regularity of prevention steps.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Asthma Management Index (AMI)</measure>
    <time_frame>15 months</time_frame>
    <description>This is one of the 3 subscales of Asthma Self-Management Indices. This subscale (9 items total) measures the number of steps taken to manage symptoms once they occur, and two response options are given, 0=no and 1=yes. Items 1-4, 6, 8 &amp; 9 were summed for a total count of management steps taken, with possible scores ranging from 0 to 7. The higher the sum scores, the greater the number of steps taken to manage symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Asthma Management Self-efficacy Index</measure>
    <time_frame>15 months</time_frame>
    <description>This is one of 3 subscales of asthma self-management indices developed for adolescents with asthma. The self-efficacy index consists of 14 items measured on a 6-point scale (1='I am very sure I could not'; 6='I am very sure I could'). An average score of all 14 items was computed, ranging from 1 to 6, with higher scores suggesting greater self-efficacy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Asthma Control Questionnaire (ACQ)</measure>
    <time_frame>15 months</time_frame>
    <description>ACQ consists of 6-items measuring asthma control based on the frequency, severity, and types of symptoms, as well as degree of activity limitation, and use of SABA in the past 7 days. Each item was responded on a 6-point scale from 0 to 6. Average scores were computed, with higher scores indicating worse asthma control.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">371</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Peer Led Asthma Self-Management</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Peer-led asthma self-management for adolescents : PLASMA will be implemented in small groups at a camp setting where paired peer-leaders will facilitate learning activities.Paired peer leaders will share and coordinate the responsibilities of facilitating group activities. Training content includes: Day 1: Asthma basics and prevention; Day 2: Asthma monitoring and management; Day 3: Communication/ psychosocial issue management/leadership training/hands-on practice in simulated peer-led group settings (role-play)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adult Led Asthma Self-Management</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The adult led asthma self-management will take place within 2 weeks of the peer-led camp to minimize the history effect. Two healthcare professionals will attend peer-leader training sessions to become familiar with the program content, then lead instructional activities. As in PLASMA, adult leaders will base their instruction on the program manual to ensure comparable program content. Adult leaders will adopt mainly a didactic format and skill demonstration.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>PLASMA</intervention_name>
    <description>A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. Group learning activities will closely align with the program manual (LTAA) that consists of three sessions. Participants will also learn and practice skills in using the peak flow meter, spacer and inhaler, daily symptom diary and asthma action plan. Besides instructional activities, participants will engage in recreational activities that each camp site.</description>
    <arm_group_label>Adult Led Asthma Self-Management</arm_group_label>
    <arm_group_label>Peer Led Asthma Self-Management</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Eligibility criteria for adolescent (camp) participants include:&#xD;
&#xD;
               1. age between 12-17 years;&#xD;
&#xD;
               2. physician-diagnosed asthma that has required health service use (preventive or&#xD;
                  acute) within 12 months prior to recruitment;&#xD;
&#xD;
               3. persistent asthma determined by current use of a control medication or presenting&#xD;
                  at least one of the following four symptom levels in the past 4 weeks, as defined&#xD;
                  by the NAEPP guidelines91:&#xD;
&#xD;
          -  &gt; 2 days/week of daytime symptoms,&#xD;
&#xD;
          -  &gt;3-4 times of nighttime awakening,&#xD;
&#xD;
          -  &gt;2 days/week of SABA use, or&#xD;
&#xD;
          -  any interference with normal activities due to asthma (4) Investigators will include&#xD;
             those with chronic health conditions except for those with conditions affecting&#xD;
             respiratory system, heart disease, pneumonia, etc., and those with moderate to severe&#xD;
             cognitive impairments; (5) primary residence located in the participating inner cities&#xD;
             based on zip codes; and (6) ability to understand spoken and written English.&#xD;
&#xD;
        Eligibility criteria for peer leaders include:&#xD;
&#xD;
          1. age between 16-20 years;&#xD;
&#xD;
          2. nomination from school teachers/nurses or healthcare providers for candidates'&#xD;
             exemplary asthma self-management, leadership, and emotional intelligence; and&#xD;
&#xD;
          3. fulfillment of eligibility criteria (2)-(6) prescribed for adolescent participants.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Adolescents who are pregnant or incarcerated at enrollment;&#xD;
&#xD;
          2. Have learning disabilities based on reports from teachers or clinicians will be&#xD;
             excluded from the study because such conditions can confound the interpretation of&#xD;
             findings;&#xD;
&#xD;
          3. Those who have serious health (other than asthma) and emotional preconditions (e.g.,&#xD;
             severe depression, anxiety disorders, schizophrenia).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>20 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University at Buffalo</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Rochester Medical Center</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Tennessee</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38163</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>October 24, 2014</study_first_submitted>
  <study_first_submitted_qc>November 13, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2014</study_first_posted>
  <results_first_submitted>January 7, 2021</results_first_submitted>
  <results_first_submitted_qc>March 11, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">April 8, 2021</results_first_posted>
  <last_update_submitted>March 11, 2021</last_update_submitted>
  <last_update_submitted_qc>March 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Rochester</investigator_affiliation>
    <investigator_full_name>Hyekyun Rhee</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>asthma</keyword>
  <keyword>adolescent</keyword>
  <keyword>intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 20, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/99/NCT02293499/ICF_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 25, 2014</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/99/NCT02293499/Prot_SAP_002.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Of 446 screened participants, 320 met eligibility criteria and were enrolled and randomized to one of the two arms. Of 72 screened peer-leaders, 51 met criteria and were enrolled as peer-leaders as outlined in the intervention arm of the study, for a total of 371 enrolled individuals.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Adult Led Asthma Self-Management</title>
          <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This arm is the adult-led control group.</description>
        </group>
        <group group_id="P2">
          <title>Peer Led Asthma Self-Management</title>
          <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This arm is the peer-led intervention group.</description>
        </group>
        <group group_id="P3">
          <title>Peer Leaders</title>
          <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This group is the peer leaders who facilitated the Peer--led intervention group intervention.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Baseline - Enrollment</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="152"/>
                <participants group_id="P2" count="168"/>
                <participants group_id="P3" count="51"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="152"/>
                <participants group_id="P2" count="168"/>
                <participants group_id="P3" count="51"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Training - Peer Leaders Only</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0">Participant number carried over from previous time point.</participants>
                <participants group_id="P2" count="0">Participant number carried over from previous time point.</participants>
                <participants group_id="P3" count="51"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="41"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="10"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Intervention - Camp</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="152">By design, they did not participate in the previous period.</participants>
                <participants group_id="P2" count="168">By design, they did not participate in the previous period.</participants>
                <participants group_id="P3" count="41"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="125"/>
                <participants group_id="P2" count="134"/>
                <participants group_id="P3" count="35"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="34"/>
                <participants group_id="P3" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>these are those not showing up at camp</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="28"/>
                <participants group_id="P3" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>3 Month Follow Up</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="149"/>
                <participants group_id="P2" count="162"/>
                <participants group_id="P3" count="39"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="134"/>
                <participants group_id="P2" count="147"/>
                <participants group_id="P3" count="29"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="10"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>6 Month Follow Up</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="148"/>
                <participants group_id="P2" count="162"/>
                <participants group_id="P3" count="35"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="131"/>
                <participants group_id="P2" count="135"/>
                <participants group_id="P3" count="28"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="27"/>
                <participants group_id="P3" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="27"/>
                <participants group_id="P3" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>9 Month Follow Up</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="148"/>
                <participants group_id="P2" count="162"/>
                <participants group_id="P3" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="122"/>
                <participants group_id="P2" count="134"/>
                <participants group_id="P3" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="28"/>
                <participants group_id="P3" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="28"/>
                <participants group_id="P3" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>12 Month Follow Up</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="146"/>
                <participants group_id="P2" count="162"/>
                <participants group_id="P3" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="120"/>
                <participants group_id="P2" count="136"/>
                <participants group_id="P3" count="28"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="26"/>
                <participants group_id="P3" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="25"/>
                <participants group_id="P3" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>15 Month Follow Up</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="146"/>
                <participants group_id="P2" count="161"/>
                <participants group_id="P3" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="124"/>
                <participants group_id="P2" count="139"/>
                <participants group_id="P3" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="22"/>
                <participants group_id="P3" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="22"/>
                <participants group_id="P3" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Adult Led Asthma Self-Management</title>
          <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This arm is the adult-led control group.</description>
        </group>
        <group group_id="B2">
          <title>Peer Led Asthma Self-Management</title>
          <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This arm is the peer--led intervention group.</description>
        </group>
        <group group_id="B3">
          <title>Peer Leaders</title>
          <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This group is the peer leaders who facilitated the Peer--led intervention group intervention.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="152"/>
            <count group_id="B2" value="168"/>
            <count group_id="B3" value="51"/>
            <count group_id="B4" value="371"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14.19" spread="1.647"/>
                    <measurement group_id="B2" value="14.33" spread="1.750"/>
                    <measurement group_id="B3" value="17.22" spread="1.270"/>
                    <measurement group_id="B4" value="14.67" spread="1.935"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="74"/>
                    <measurement group_id="B2" value="78"/>
                    <measurement group_id="B3" value="33"/>
                    <measurement group_id="B4" value="185"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="78"/>
                    <measurement group_id="B2" value="90"/>
                    <measurement group_id="B3" value="18"/>
                    <measurement group_id="B4" value="186"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="135"/>
                    <measurement group_id="B2" value="155"/>
                    <measurement group_id="B3" value="50"/>
                    <measurement group_id="B4" value="340"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Caucasian/White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>African American/Black</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="120"/>
                    <measurement group_id="B2" value="131"/>
                    <measurement group_id="B3" value="40"/>
                    <measurement group_id="B4" value="291"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>American Indian/Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bi-racial/Multi-racial</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>The Pediatric Asthma Quality of Life Questionnaire (PAQOL)</title>
        <description>a 23-item instrument, 118 consists of three subdomains: activity limitation (5 items), emotional function (8 items), and symptoms (10 items). Higher scores indicate better levels of functioning. This scale has proved a valid and reliable measure of asthma-specific quality of life in adolescents. Mean scores are reported, and range from 1 to 7. Higher score indicating higher quality of life.</description>
        <time_frame>15 months</time_frame>
        <population>Number of participants analyzed included only those who had data collected at 15 months.</population>
        <group_list>
          <group group_id="O1">
            <title>Adult Led Asthma Self-Management</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This arm is the adult-led control group.</description>
          </group>
          <group group_id="O2">
            <title>Peer Led Asthma Self-Management</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This arm is the peer-led intervention group.</description>
          </group>
          <group group_id="O3">
            <title>Peer Leaders</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This group is the peer leaders who facilitated the Peer--led intervention group intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>The Pediatric Asthma Quality of Life Questionnaire (PAQOL)</title>
          <description>a 23-item instrument, 118 consists of three subdomains: activity limitation (5 items), emotional function (8 items), and symptoms (10 items). Higher scores indicate better levels of functioning. This scale has proved a valid and reliable measure of asthma-specific quality of life in adolescents. Mean scores are reported, and range from 1 to 7. Higher score indicating higher quality of life.</description>
          <population>Number of participants analyzed included only those who had data collected at 15 months.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="139"/>
                <count group_id="O2" value="124"/>
                <count group_id="O3" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.58" spread="1.36"/>
                    <measurement group_id="O2" value="5.93" spread="1.2"/>
                    <measurement group_id="O3" value="6.49" spread="0.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For each model, partial eta squared (2) was reported as the effect size for the change between treatment groups (Adult led vs. peer led asthma self-management). Partial2 is the proportion of variance explained by a given variable out of the variance remaining after excluding variance explained by other predictors. Partial 2&gt; 0.14 indicates large effects, while 2= 0.06 to 0.14 medium and &lt; 0.06 small effects</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.043</p_value>
            <p_value_desc>A priori threshold for statistical significance is &lt;.05.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>partial eta squared</param_type>
            <param_value>.003</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>For each model, partial eta squared (2) was reported as the effect size for the overall change over time. Partial2 is the proportion of variance explained by a given variable out of the variance remaining after excluding variance explained by other predictors. Partial 2&gt; 0.14 indicates large effects, while 2= 0.06 to 0.14 medium and &lt; 0.06 small effects</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.00</p_value>
            <p_value_desc>A priori threshold for statistical significance is &lt;.05.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>partial eta squared</param_type>
            <param_value>.21</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Mediator analysis of AMI-SEI subscale on quality of life</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.0079</p_value>
            <method>Sobel</method>
            <param_type>Sobel Statistic</param_type>
            <param_value>2.4119</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Mediator analysis of ACQ Total score subscale on quality of life</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.0172</p_value>
            <method>Sobel</method>
            <param_type>Sobel Statistic</param_type>
            <param_value>2.1132</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Adolescent Asthma Knowledge Questionnaire (AAK)</title>
        <description>This 30-item instrument is a modification of the original 27-item questionnaire measuring children's knowledge of triggers and symptom identification and asthma management procedures. Total score range from 0 to 30, with higher score indicating greater knowledge.</description>
        <time_frame>15 months</time_frame>
        <population>Number of participants analyzed included only those who had data collected at 15 months.</population>
        <group_list>
          <group group_id="O1">
            <title>Adult Led Asthma Self-Management</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This arm is the adult-led control group.</description>
          </group>
          <group group_id="O2">
            <title>Peer Led Asthma Self-Management</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This arm is the peer-led intervention group.</description>
          </group>
          <group group_id="O3">
            <title>Peer Leaders</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This group is the peer leaders who facilitated the Peer--led intervention group intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Adolescent Asthma Knowledge Questionnaire (AAK)</title>
          <description>This 30-item instrument is a modification of the original 27-item questionnaire measuring children's knowledge of triggers and symptom identification and asthma management procedures. Total score range from 0 to 30, with higher score indicating greater knowledge.</description>
          <population>Number of participants analyzed included only those who had data collected at 15 months.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="131"/>
                <count group_id="O2" value="124"/>
                <count group_id="O3" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.07" spread="4.13"/>
                    <measurement group_id="O2" value="23.53" spread="4.16"/>
                    <measurement group_id="O3" value="25.85" spread="3.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For each model, partial eta squared (2) was reported as the effect size for the change between treatment groups (Adult led vs. peer led asthma self-management). Partial2 is the proportion of variance explained by a given variable out of the variance remaining after excluding variance explained by other predictors. Partial 2&gt; 0.14 indicates large effects, while 2= 0.06 to 0.14 medium and &lt; 0.06 small effects</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.295</p_value>
            <p_value_desc>A priori threshold for statistical significance is &lt;.05.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>partial eta squared</param_type>
            <param_value>.001</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>For each model, partial eta squared (2) was reported as the effect size for the overall change over time. Partial2 is the proportion of variance explained by a given variable out of the variance remaining after excluding variance explained by other predictors. Partial 2&gt; 0.14 indicates large effects, while 2= 0.06 to 0.14 medium and &lt; 0.06 small effects</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.00</p_value>
            <p_value_desc>A priori threshold for statistical significance is &lt;.05.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>partial eta squared</param_type>
            <param_value>.15</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Attitude Toward Asthma Scale (ATA)</title>
        <description>This 13-item scale measures children's attitudes toward their asthma on a 5-point Likert-type scale. Mean score ranges from 1 to 5, with higher score indicating a more positive attitude.</description>
        <time_frame>15 months</time_frame>
        <population>Number of participants analyzed included only those who had data collected at 15 months.</population>
        <group_list>
          <group group_id="O1">
            <title>Adult Led Asthma Self-Management</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This arm is the adult-led control group.</description>
          </group>
          <group group_id="O2">
            <title>Peer Led Asthma Self-Management</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This arm is the peer-led intervention group.</description>
          </group>
          <group group_id="O3">
            <title>Peer Leaders</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This group is the peer leaders who facilitated the Peer--led intervention group intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Attitude Toward Asthma Scale (ATA)</title>
          <description>This 13-item scale measures children's attitudes toward their asthma on a 5-point Likert-type scale. Mean score ranges from 1 to 5, with higher score indicating a more positive attitude.</description>
          <population>Number of participants analyzed included only those who had data collected at 15 months.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="136"/>
                <count group_id="O2" value="124"/>
                <count group_id="O3" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.58" spread="0.73"/>
                    <measurement group_id="O2" value="3.77" spread="0.67"/>
                    <measurement group_id="O3" value="3.95" spread="0.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For each model, partial eta squared (2) was reported as the effect size for the change between treatment groups (Adult led vs. peer led asthma self-management). Partial2 is the proportion of variance explained by a given variable out of the variance remaining after excluding variance explained by other predictors. Partial 2&gt; 0.14 indicates large effects, while 2= 0.06 to 0.14 medium and &lt; 0.06 small effects</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.140</p_value>
            <p_value_desc>A priori threshold for statistical significance is &lt;.05.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>partial eta squared</param_type>
            <param_value>.002</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>For each model, partial eta squared (2) was reported as the effect size for the overall change over time. Partial2 is the proportion of variance explained by a given variable out of the variance remaining after excluding variance explained by other predictors. Partial 2&gt; 0.14 indicates large effects, while 2= 0.06 to 0.14 medium and &lt; 0.06 small effects</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.00</p_value>
            <p_value_desc>A priori threshold for statistical significance is &lt;.05.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>partial eta squared</param_type>
            <param_value>.15</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Asthma Self-Efficacy (ASE)</title>
        <description>This 14-item instrument measured on a 5-point scale (from 1='not at all sure' to 5='completely sure') assesses a child's confidence in attack prevention (e.g., learning asthma self-management skills, correct use of medication) and attack management (e.g., control symptoms, decide which medication to use). A total score was computed, ranging from 14 and 70, with higher values indicating greater self-efficacy.</description>
        <time_frame>15 months</time_frame>
        <population>Number of participants analyzed included only those who had data collected at 15 months.</population>
        <group_list>
          <group group_id="O1">
            <title>Adult Led Asthma Self-Management</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This arm is the adult-led control group.</description>
          </group>
          <group group_id="O2">
            <title>Peer Led Asthma Self-Management</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This arm is the peer-led intervention group.</description>
          </group>
          <group group_id="O3">
            <title>Peer Leaders</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This group is the peer leaders who facilitated the Peer--led intervention group intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Asthma Self-Efficacy (ASE)</title>
          <description>This 14-item instrument measured on a 5-point scale (from 1='not at all sure' to 5='completely sure') assesses a child's confidence in attack prevention (e.g., learning asthma self-management skills, correct use of medication) and attack management (e.g., control symptoms, decide which medication to use). A total score was computed, ranging from 14 and 70, with higher values indicating greater self-efficacy.</description>
          <population>Number of participants analyzed included only those who had data collected at 15 months.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="134"/>
                <count group_id="O2" value="124"/>
                <count group_id="O3" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.38" spread="11.46"/>
                    <measurement group_id="O2" value="58.36" spread="11.79"/>
                    <measurement group_id="O3" value="63.62" spread="8.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For each model, partial eta squared (2) was reported as the effect size for the change between treatment groups (Adult led vs. peer led asthma self-management). Partial2 is the proportion of variance explained by a given variable out of the variance remaining after excluding variance explained by other predictors. Partial 2&gt; 0.14 indicates large effects, while 2= 0.06 to 0.14 medium and &lt; 0.06 small effects</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.268</p_value>
            <p_value_desc>A priori threshold for statistical significance is &lt;.05.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>partial eta squared</param_type>
            <param_value>.001</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>For each model, partial eta squared (2) was reported as the effect size for the overall change over time. Partial2 is the proportion of variance explained by a given variable out of the variance remaining after excluding variance explained by other predictors. Partial 2&gt; 0.14 indicates large effects, while 2= 0.06 to 0.14 medium and &lt; 0.06 small effects</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.14</p_value>
            <p_value_desc>A priori threshold for statistical significance is &lt;.05.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>partial eta squared</param_type>
            <param_value>.06</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Asthma Outcome Expectation Scale (AOE)</title>
        <description>This 5 items scale measured on a 9-point scale from 'not all all (1)' to 'extremely (9)' assess the construct of &quot;outcome expectations&quot; derived from social cognitive theory. The average score was computed, ranging from 1 to 9, with higher scores suggesting more positive expectations about performing actions of asthma self-management.</description>
        <time_frame>15 months</time_frame>
        <population>Number of participants analyzed included only those who had data collected at 15 months.</population>
        <group_list>
          <group group_id="O1">
            <title>Adult Led Asthma Self-Management</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This arm is the adult-led control group.</description>
          </group>
          <group group_id="O2">
            <title>Peer Led Asthma Self-Management</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This arm is the peer-led intervention group.</description>
          </group>
          <group group_id="O3">
            <title>Peer Leaders</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This group is the peer leaders who facilitated the Peer--led intervention group intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Asthma Outcome Expectation Scale (AOE)</title>
          <description>This 5 items scale measured on a 9-point scale from 'not all all (1)' to 'extremely (9)' assess the construct of &quot;outcome expectations&quot; derived from social cognitive theory. The average score was computed, ranging from 1 to 9, with higher scores suggesting more positive expectations about performing actions of asthma self-management.</description>
          <population>Number of participants analyzed included only those who had data collected at 15 months.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="135"/>
                <count group_id="O2" value="124"/>
                <count group_id="O3" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.87" spread="1.38"/>
                    <measurement group_id="O2" value="6" spread="1.05"/>
                    <measurement group_id="O3" value="6.27" spread="1.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For each model, partial eta squared (2) was reported as the effect size for the change between treatment groups (Adult led vs. peer led asthma self-management). Partial2 is the proportion of variance explained by a given variable out of the variance remaining after excluding variance explained by other predictors. Partial 2&gt; 0.14 indicates large effects, while 2= 0.06 to 0.14 medium and &lt; 0.06 small effects</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.238</p_value>
            <p_value_desc>A priori threshold for statistical significance is &lt;.05.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>partial eta squared</param_type>
            <param_value>.001</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>For each model, partial eta squared (2) was reported as the effect size for the overall change over time. Partial2 is the proportion of variance explained by a given variable out of the variance remaining after excluding variance explained by other predictors. Partial 2&gt; 0.14 indicates large effects, while 2= 0.06 to 0.14 medium and &lt; 0.06 small effects</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.43</p_value>
            <p_value_desc>A priori threshold for statistical significance is &lt;.05.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>partial eta squared</param_type>
            <param_value>.03</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.024</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Slope</param_type>
            <param_value>-.203</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Asthma Prevention Index</title>
        <description>This is one of 3 subscales of asthma self-management indices developed for adolescents with asthma. The prevention index consists of 11 items measured on a 3-point scale. An average score based on items 1-9 was computed, ranging from 1 to 3, with higher scores suggesting greater regularity of prevention steps.</description>
        <time_frame>15 months</time_frame>
        <population>Number of participants analyzed included only those who had data collected at 15 months.</population>
        <group_list>
          <group group_id="O1">
            <title>Adult Led Asthma Self-Management</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This arm is the adult-led control group.</description>
          </group>
          <group group_id="O2">
            <title>Peer Led Asthma Self-Management</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This arm is the peer-led intervention group.</description>
          </group>
          <group group_id="O3">
            <title>Peer Leaders</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This group is the peer leaders who facilitated the Peer--led intervention group intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Asthma Prevention Index</title>
          <description>This is one of 3 subscales of asthma self-management indices developed for adolescents with asthma. The prevention index consists of 11 items measured on a 3-point scale. An average score based on items 1-9 was computed, ranging from 1 to 3, with higher scores suggesting greater regularity of prevention steps.</description>
          <population>Number of participants analyzed included only those who had data collected at 15 months.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="136"/>
                <count group_id="O2" value="124"/>
                <count group_id="O3" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.20" spread="0.51"/>
                    <measurement group_id="O2" value="2.11" spread="0.56"/>
                    <measurement group_id="O3" value="2.18" spread="0.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For each model, partial eta squared (2) was reported as the effect size for the change between treatment groups (Adult led vs. peer led asthma self-management). Partial2 is the proportion of variance explained by a given variable out of the variance remaining after excluding variance explained by other predictors. Partial 2&gt; 0.14 indicates large effects, while 2= 0.06 to 0.14 medium and &lt; 0.06 small effects</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.484</p_value>
            <p_value_desc>A priori threshold for statistical significance is &lt;.05.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>partial eta squared</param_type>
            <param_value>.000</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>For each model, partial eta squared (2) was reported as the effect size for the overall change over time. Partial2 is the proportion of variance explained by a given variable out of the variance remaining after excluding variance explained by other predictors. Partial 2&gt; 0.14 indicates large effects, while 2= 0.06 to 0.14 medium and &lt; 0.06 small effects</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.00</p_value>
            <p_value_desc>A priori threshold for statistical significance is &lt;.05.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>partial eta squared</param_type>
            <param_value>.12</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Asthma Management Index (AMI)</title>
        <description>This is one of the 3 subscales of Asthma Self-Management Indices. This subscale (9 items total) measures the number of steps taken to manage symptoms once they occur, and two response options are given, 0=no and 1=yes. Items 1-4, 6, 8 &amp; 9 were summed for a total count of management steps taken, with possible scores ranging from 0 to 7. The higher the sum scores, the greater the number of steps taken to manage symptoms.</description>
        <time_frame>15 months</time_frame>
        <population>Number of participants analyzed included only those who had data collected at 15 months.</population>
        <group_list>
          <group group_id="O1">
            <title>Adult Led Asthma Self-Management</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This arm is the adult-led control group.</description>
          </group>
          <group group_id="O2">
            <title>Peer Led Asthma Self-Management</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This arm is the peer--led intervention group.</description>
          </group>
          <group group_id="O3">
            <title>Peer Leaders</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This group is the peer leaders who facilitated the Peer--led intervention group intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Asthma Management Index (AMI)</title>
          <description>This is one of the 3 subscales of Asthma Self-Management Indices. This subscale (9 items total) measures the number of steps taken to manage symptoms once they occur, and two response options are given, 0=no and 1=yes. Items 1-4, 6, 8 &amp; 9 were summed for a total count of management steps taken, with possible scores ranging from 0 to 7. The higher the sum scores, the greater the number of steps taken to manage symptoms.</description>
          <population>Number of participants analyzed included only those who had data collected at 15 months.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="136"/>
                <count group_id="O2" value="124"/>
                <count group_id="O3" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.51" spread="1.54"/>
                    <measurement group_id="O2" value="5.67" spread="1.31"/>
                    <measurement group_id="O3" value="5.04" spread="1.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For each model, partial eta squared (2) was reported as the effect size for the change between treatment groups (Adult led vs. peer led asthma self-management). Partial2 is the proportion of variance explained by a given variable out of the variance remaining after excluding variance explained by other predictors. Partial 2&gt; 0.14 indicates large effects, while 2= 0.06 to 0.14 medium and &lt; 0.06 small effects</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.648</p_value>
            <p_value_desc>A priori threshold for statistical significance is &lt;.05.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>partial eta squared</param_type>
            <param_value>.000</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>For each model, partial eta squared (2) was reported as the effect size for the overall change over time. Partial2 is the proportion of variance explained by a given variable out of the variance remaining after excluding variance explained by other predictors. Partial 2&gt; 0.14 indicates large effects, while 2= 0.06 to 0.14 medium and &lt; 0.06 small effects</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.04</p_value>
            <p_value_desc>A priori threshold for statistical significance is &lt;.05.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>partial eta squared</param_type>
            <param_value>.07</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Asthma Management Self-efficacy Index</title>
        <description>This is one of 3 subscales of asthma self-management indices developed for adolescents with asthma. The self-efficacy index consists of 14 items measured on a 6-point scale (1='I am very sure I could not'; 6='I am very sure I could'). An average score of all 14 items was computed, ranging from 1 to 6, with higher scores suggesting greater self-efficacy.</description>
        <time_frame>15 months</time_frame>
        <population>Number of participants analyzed included only those who had data collected at 15 months.</population>
        <group_list>
          <group group_id="O1">
            <title>Adult Led Asthma Self-Management</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This arm is the adult-led control group.</description>
          </group>
          <group group_id="O2">
            <title>Peer Led Asthma Self-Management</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This arm is the peer--led intervention group.</description>
          </group>
          <group group_id="O3">
            <title>Peer Leaders</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This group is the peer leaders who facilitated the Peer--led intervention group intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Asthma Management Self-efficacy Index</title>
          <description>This is one of 3 subscales of asthma self-management indices developed for adolescents with asthma. The self-efficacy index consists of 14 items measured on a 6-point scale (1='I am very sure I could not'; 6='I am very sure I could'). An average score of all 14 items was computed, ranging from 1 to 6, with higher scores suggesting greater self-efficacy.</description>
          <population>Number of participants analyzed included only those who had data collected at 15 months.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="136"/>
                <count group_id="O2" value="124"/>
                <count group_id="O3" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.79" spread="1.05"/>
                    <measurement group_id="O2" value="4.96" spread="0.85"/>
                    <measurement group_id="O3" value="5.40" spread="0.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For each model, partial eta squared (2) was reported as the effect size for the change between treatment groups (Adult led vs. peer led asthma self-management). Partial2 is the proportion of variance explained by a given variable out of the variance remaining after excluding variance explained by other predictors. Partial 2&gt; 0.14 indicates large effects, while 2= 0.06 to 0.14 medium and &lt; 0.06 small effects</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.020</p_value>
            <p_value_desc>A priori threshold for statistical significance is &lt;.05.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>partial eta squared</param_type>
            <param_value>.003</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>For each model, partial eta squared (2) was reported as the effect size for the overall change over time. Partial2 is the proportion of variance explained by a given variable out of the variance remaining after excluding variance explained by other predictors. Partial 2&gt; 0.14 indicates large effects, while 2= 0.06 to 0.14 medium and &lt; 0.06 small effects</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.23</p_value>
            <p_value_desc>A priori threshold for statistical significance is &lt;.05</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>partial eta squared</param_type>
            <param_value>.04</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Asthma Control Questionnaire (ACQ)</title>
        <description>ACQ consists of 6-items measuring asthma control based on the frequency, severity, and types of symptoms, as well as degree of activity limitation, and use of SABA in the past 7 days. Each item was responded on a 6-point scale from 0 to 6. Average scores were computed, with higher scores indicating worse asthma control.</description>
        <time_frame>15 months</time_frame>
        <population>Number of participants analyzed included only those who had data collected at 15 months.</population>
        <group_list>
          <group group_id="O1">
            <title>Adult Led Asthma Self-Management</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This arm is the adult-led control group.</description>
          </group>
          <group group_id="O2">
            <title>Peer Led Asthma Self-Management</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This arm is the peer-led intervention group.</description>
          </group>
          <group group_id="O3">
            <title>Peer Leaders</title>
            <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This group is the peer leaders who facilitated the Peer--led intervention group intervention.</description>
          </group>
        </group_list>
        <measure>
          <title>Asthma Control Questionnaire (ACQ)</title>
          <description>ACQ consists of 6-items measuring asthma control based on the frequency, severity, and types of symptoms, as well as degree of activity limitation, and use of SABA in the past 7 days. Each item was responded on a 6-point scale from 0 to 6. Average scores were computed, with higher scores indicating worse asthma control.</description>
          <population>Number of participants analyzed included only those who had data collected at 15 months.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="139"/>
                <count group_id="O2" value="124"/>
                <count group_id="O3" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.15" spread="1.01"/>
                    <measurement group_id="O2" value="0.92" spread="1.06"/>
                    <measurement group_id="O3" value="0.44" spread="0.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For each model, partial eta squared (2) was reported as the effect size for the change between treatment groups (Adult led vs. peer led asthma self-management). Partial2 is the proportion of variance explained by a given variable out of the variance remaining after excluding variance explained by other predictors. Partial 2&gt; 0.14 indicates large effects, while 2= 0.06 to 0.14 medium and &lt; 0.06 small effects</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.049</p_value>
            <p_value_desc>A priori threshold for statistical significance is &lt;.05.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>partial eta squared</param_type>
            <param_value>.002</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>For each model, partial eta squared (2) was reported as the effect size for the overall change over time. Partial2 is the proportion of variance explained by a given variable out of the variance remaining after excluding variance explained by other predictors. Partial 2&gt; 0.14 indicates large effects, while 2= 0.06 to 0.14 medium and &lt; 0.06 small effects</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.00</p_value>
            <p_value_desc>A priori threshold for statistical significance is &lt;.05</p_value_desc>
            <method>Mixed Models Analysis</method>
            <param_type>partial eta squared</param_type>
            <param_value>.12</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.004</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Slope</param_type>
            <param_value>-.294</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Mediator analysis of AMI-SEI subscale on ACQ total</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.0093</p_value>
            <method>Sobel</method>
            <param_type>Sobel Statistic</param_type>
            <param_value>-2.3505</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Study time frame of 15 months from baseline to final follow up with participants.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Adult Led Asthma Self-Management</title>
          <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This arm is the adult-led control group.</description>
        </group>
        <group group_id="E2">
          <title>Peer Led Asthma Self-Management</title>
          <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This arm is the peer-led intervention group.</description>
        </group>
        <group group_id="E3">
          <title>Peer Leaders</title>
          <description>PLASMA: A structured asthma self-management manual (&quot;Let's Talk about Asthma [LTAA],&quot;developed by the study team will be utilized in a camp like setting and administered by either peers or adults medical professionals. The manual adheres to the 2007 NAEPP Guidelines Training strategies will involve didactic sessions, discussion, demonstrations, and role-play. This group is the peer leaders who facilitated the Peer--led intervention group intervention.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="168"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Hyekyun Rhee PhD, RN, FAAN</name_or_title>
      <organization>University of Rochester School of Nursing</organization>
      <phone>585-276-3775</phone>
      <email>Hyekyun_Rhee@urmc.rochester.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

